Month: June 2024

Study published in peer-reviewed journal finds BioStem’s products offer overall better treatment efficiency, and greater efficiency in general wound closure POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that an article validating its proprietary processing method and its placental allograft products has been published in the international, peer-reviewed journal, Health Science Reports. The article, titled Assessing placental membrane treatment efficiency in diabetic foot ulcers: Processing for retention versus lamination provides a retrospective analysis of wound care in 41 subjects. The study’s primary objective...

Additional patents issued for 10 plant trait and editing families in the past two quarters. Strengthens Cibus’ intellectual property portfolio in its Pod Shatter Reduction (PSR), Herbicide Tolerances (HTs), High Fiber Wheat and Improved Quality Alfalfa trait families. SAN DIEGO, June 26, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has expanded its intellectual property coverage for 10 gene editing and trait families. This intellectual property expansion over the last 6 months covers several areas including gene editing, productivity traits and quality traits, like high fiber wheat, strengthening the Company’s patent coverage in geographies including, but not limited to, Europe (EPO),...

BranchOut Food contracts with the retailer now total approximately $8 million in annualized revenue New dried vegetable offerings have shipped ahead of a nationwide launch in July 2024 BEND, Ore., June 26, 2024 (GLOBE NEWSWIRE) — BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced it has shipped the first production of the new products that will be launched nationwide in July 2024 by the nation’s largest retailer. The dried brussels sprouts, a first-to-market offering, and dried carrot sticks are innovative new products requested by the retailer. Eric Healy, CEO of BranchOut Food, said, “We are excited to continue growing our relationship as a trusted partner to this large, brand-name retailer. In addition to the products shipped this...

AXA is the 2nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume and Revenue AXA Represents the First Insurance Company to Approve Payment for Nociscan BROOMFIELD, CO, June 26, 2024 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today their initial payer coverage of Nociscan by AXA in London, UK in conjunction with The London Clinic, one of the UK’s largest and most renowned independent hospitals. AXA is a leading provider of private medical insurance in the UK. “Securing first payer coverage is the most significant...

Ongoing Study is Investigating RenovoGem™ to treat Locally Advanced Pancreatic Cancer LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced today that the University of Nebraska Medical Center (UNMC) is now enrolling patients with Locally Advanced Pancreatic Cancer (LAPC) in the Company’s ongoing pivotal Phase III TIGeR-PaC clinical trial. The TIGeR-PaC study is using RenovoRx’s patented TAMP (Trans-Arterial Micro-Perfusion) therapy platform to evaluate its RenovoGem investigational drug-device combination product. RenovoGem utilizes pressure-mediated delivery of chemotherapy across the arterial wall to bathe tumor tissue. The...

Designed to celebrate the rich and diverse culture of Singapore Reports successful launch with plans to rapidly expand Company’s own branded products within the multi-billion-dollar global gift market Singapore, June 26, 2024 (GLOBE NEWSWIRE) —  Webuy Global Ltd. (Nasdaq: WBUY) (“Webuy” or the “Company”), a Southeast Asian community e-commerce retailer, today announced the launch of its Sing Select gift series, a new line of high-quality, thoughtfully curated gift sets designed to celebrate the rich and diverse culture of Singapore. The series was officially launched in May 2024 with the Plum Wine Gift Set as the first proprietary product in the series. Consumer demand for the Plum Wine Gift Set has exceeded expectations, with more than 700 sets sold in a single day. Building on the initial success of the Plum Wine Gift Set, Webuy...

Trading to Continue Under Same Ticker Symbol OMQS Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) — OMNIQ Corp. (OTC PINK: OMQS) (“OMNIQ” or “the Company”), a leading provider of Artificial Intelligence (AI)-based solutions for supply chain management and data processing, today announced that its stock has transitioned from NASDAQ to the OTC Markets. OMNIQ’s stock continues to trade under the ticker symbol OMQS, ensuring uninterrupted market activity for its shareholders. OMNIQ remains committed to maintaining the highest standards of corporate governance and transparency. Nasdaq determination to delist the company’s stock, effective May 7, 2024, is due to not meeting the minimum market value requirement of $35 million. OMNIQ remains fully compliant with all other regulatory guidelines and is actively taking steps to be relisted...

VANCOUVER, BC, June 26, 2024 (GLOBE NEWSWIRE) — AMERICAN SALARS LITHIUM INC. (“AMERICAN SALARS” OR THE “COMPANY”) (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY) announces it has received confirmation that the ALS Geochemistry Laboratory in Reno Nevada has received 121 samples collected from the Company’s 100% owned Black Rock South Lithium Brine Project, located 11 miles north of the “Galt” claim group under option to Surge Battery Metals (CSE: NILI). Samples will be processed using Boyd RSD rotary crushers and splitter with a 180-micron (80 mesh) sieve, aqua regia digestion, and 41 multi-element ICP-AES analysis (code ME-ICP41). Black Rock South Highlights58 soil samples were collected across and around the Black Rock South property Land Research was completed in the vicinity of the property 63 prospecting...

These C-Bond BRS installations will be completed by trained local installers in C-Bond’s growing dealer network, which includes 50 dealers SAN ANTONIO, June 26, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, today announced that its Patriot Glass Solutions subsidiary continues to broaden its geographic reach with two new purchase orders to install C-Bond BRS (ballistic-resistant system) at a United Services Automobile Association (USAA) location in North Carolina and a courthouse in Oklahoma. Patriot Glass Solutions will custom-cut the ballistic-resistant film and the installations will be completed by trained local film installers in C-Bond’s growing dealer network, which now includes 50 dealers. C-Bond BRS is a ballistic-resistant...

WILMINGTON, Mass., June 26, 2024 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its third quarter ended May 25, 2024 as compared to the corresponding period in the prior fiscal year: Q3 2024 Financial HighlightsConsolidated revenues for the third quarter increased 4.6% to $603.3 million. Operating income was $48.5 million, an increase of 45.1%. The quarterly tax rate decreased to 22.9% compared to 27.2% in the prior year. Net income increased to $38.1 million from $24.3 million in the prior year, or 56.8%. Diluted earnings per share increased to $2.03 from $1.29 in the prior year, or 57.4%. EBITDA increased to $82.5 million compared to $64.0 million in the prior year, or 29.0%. Cash flow from operating activities increased to $193.0 million in the first nine...